Skip to content

Donate Crypto, Stocks & Other Financial Gifts

Stocks & Other Financial Gifts

Ways to Give

Choose which type of financial gift you would like to make

No Title

Gifts of Stock

Donating appreciated stocks, bonds, mutual funds, or exchange-traded funds helps us achieve our mission, while offering an easy way to maximize your potential tax benefits. You or your financial advisor can make a stock gift online in less than 5 minutes. To learn more, access our transfer information.

No Title

IRA Distributions

If you are 70.5 or older, you are eligible to make a gift from your IRA that benefits you while supporting Ovarian Cancer Research Alliance. If you are 72 or older and need to fulfill a Required Minimum Distribution (RMD), an IRA gift can help you do so while enabling you to avoid a hefty tax penalty.

No Title

Donor-Advised Funds

Donor-advised funds (DAF) are charitable-giving vehicles administered by a qualified public charity. Think of it as a savings account specifically earmarked for philanthropic activities. After you establish a DAF, you can make contributions as often as you wish and receive an immediate charitable deduction. When you are ready, you can then recommend a grant to OCRA.

Donate Cryptocurrency

Donating cryptocurrency is a fast, secure way to fund cutting-edge research to fight ovarian and related gynecologic cancers and increase vital patient support, education, and advocacy activities.

Cryptocurrency donations are also non-taxable, meaning you do not owe capital gains tax on the appreciated amount and can deduct it on your taxes.

Learn more about donating crypto

We accept the following cryptocurrencies: Bitcoin (BTC), Ethereum (ETH), Basic Attention Token (BAT), Aave (AAVE), Alchemix (ALCX), Amp (AMP), Ankr Network (ANKR), Axie Infinity Shards (AXS), Balancer (BAL), Bancor Network Token (BNT), BarnBridge (BOND), Bitcoin Cash (BCH), ChainLink (LINK), Compound (COMP), Curve (CRV), Dai (DAI), Decentraland (MANA), Dogecoin (DOGE), Enjin Coin (ENJ), Fantom (FTM), Filecoin (FIL), Gemini Dollar (GUSD), Injective Protocol (INJ), Kyber Network (KNC), Litecoin (LTC), Livepeer (LPT), Loopring (LRC), Maker (MKR), Mirror Protocol (MIR), Moss Carbon Credit (MCO2), Orchid (OXT), PAX Gold (PAXG), Polygon (MATIC), Ren (REN), Skale (SKL), Somnium Space (CUBE), Storj (STORJ), SushiSwap (SUSHI), Synthetix (SNX), Tezos (XTZ), The Graph (GRT), The Sandbox (SAND), Smooth Love Potion (SLP), Terra (LUNA), TerraUSD (UST), UMA (UMA), Uniswap (UNI), Yearn.Finance (YFI), Zcash (ZEC), 0x (ZRX), 1inch (1INCH)

Related Topics

OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer

OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer

A new study published February 2 in JAMA Network Open provides the clearest evidence to date that opportunistic salpingectomy—the removal of the fallopian tubes during another gynecologic surgery—can dramatically reduce the risk of ovarian cancer. Led by a B.C.-based international collaboration known as the Ovarian Cancer Observatory, the study found that people who underwent opportunistic … Continued

Read more

(Webinar) – Ask the Experts: Gynecologic Sarcoma

(Webinar) – Ask the Experts: Gynecologic Sarcoma

Watch Now: Ask the Experts Webinar on Gynecologic Sarcoma On January 28, 2026, Ovarian Cancer Research Alliance (OCRA) hosted a live Ask the Experts: Gynecologic Sarcoma webinar with Matthew Hemming, MD, PhD. Moderated by Liza Lundgren, LCSW, OCRA’s Director of Education, this free session featured a live discussion and audience Q&A focused on gynecologic sarcoma research, … Continued

Read more

Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection

Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection

The Congressional Appropriations Committees have released a combined FY2026  Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress for our community, but it is not final. Congress must act swiftly to advance and … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.